AAAAAA
Results: 26-43/43
Authors:
Van Beers, BE
Materne, R
Lacrosse, M
Jamart, J
Smith, AM
Horsmans, Y
Gigot, JF
Gilon, R
Pringot, J
Citation: Be. Van Beers et al., MR imaging of hypervascular liver tumors: Timing optimization during the arterial phase, J MAGN R I, 9(4), 1999, pp. 562-567
Authors:
Sempoux, C
Starkel, P
Stevens, M
Van Den Berge, V
Horsmans, Y
Citation: C. Sempoux et al., Cytochrome P450 3A proteins are expressed in B lymphocytes but not in T lymphocytes, PHARMACOGEN, 9(2), 1999, pp. 263-265
Authors:
Horsmans, Y
Citation: Y. Horsmans, New treatments for hepatitis B, ARCH PED, 6, 1999, pp. 180S-182S
Authors:
Starkel, P
Horsmans, Y
Sempoux, C
De Saeger, C
Wary, J
Lause, P
Maiter, D
Lambotte, L
Citation: P. Starkel et al., After portal branch ligation in rat, nuclear factor kappa B, interleukin-6, signal transducers and activators of transcription 3, c-fos, c-myc, and c-jun are similarly induced in the ligated and nonligated lobes, HEPATOLOGY, 29(5), 1999, pp. 1463-1470
Authors:
Horsmans, Y
Karayiannis, P
Christophe, JL
Pickering, JM
Debauche, C
Cornu, C
Rahier, J
Hess, G
Thomas, HC
Geubel, AP
Citation: Y. Horsmans et al., Severe exacerbation of liver disease during pregnancy in a thalassemic GBV-C/HGV-positive patient and neonatal hepatitis in offspring, J MED VIROL, 57(2), 1999, pp. 122-125
Authors:
Nakad, A
Bataille, L
Hamoir, V
Sempoux, C
Horsmans, Y
Citation: A. Nakad et al., Atorvastatin-induced acute hepatitis with absence of cross-toxicity with simvastatin, LANCET, 353(9166), 1999, pp. 1763-1764
Authors:
Starkel, P
Sempoux, C
Van den Berge, V
Stevens, M
De Saeger, C
Desager, JP
Horsmans, Y
Citation: P. Starkel et al., CYP 3A proteins are expressed in human neutrophils and lymphocytes but arenot induced by rifampicin, LIFE SCI, 64(8), 1999, pp. 643-653
Authors:
Hautekeete, ML
Horsmans, Y
van Waeyenberge, C
Demanet, C
Henrion, J
Verbist, L
Brenard, R
Sempoux, C
Michielsen, PP
Yap, PSH
Rahier, J
Geubel, AP
Citation: Ml. Hautekeete et al., HLA association of amoxicillin-clavulanate-induced hepatitis, GASTROENTY, 117(5), 1999, pp. 1181-1186
Dietary restriction of energy and sugar results in a reduction in human cytochrome P450 2E1 activity
Authors:
Leclercq, I
Horsmans, Y
Desager, JP
Pauwels, S
Geubel, AP
Citation: I. Leclercq et al., Dietary restriction of energy and sugar results in a reduction in human cytochrome P450 2E1 activity, BR J NUTR, 82(4), 1999, pp. 257-262
Authors:
Horsmans, Y
De Clercq, M
Sempoux, C
Citation: Y. Horsmans et al., Venlaxafine-associated hepatitis, ANN INT MED, 130(11), 1999, pp. 944-944
Authors:
Horsmans, Y
Citation: Y. Horsmans, New drugs in chronic hepatitis B, ACT GASTR B, 62(4), 1999, pp. 440-442
Authors:
Lerut, J
Laterre, PF
Roggen, F
Ciccarelli, O
Donataccio, M
Martinez, J
de Goyet, JD
Reding, R
Carlier, MA
Dekock, M
Lavand'homme, P
Van Obbergh, L
Veyckemans, F
Janssen, M
Danse, E
Goffette, P
Van Beers, B
Sempoux, C
Wallemacq, P
Peeters, A
Guerrieri, C
Roeseler, J
Latinne, D
Goubau, P
Horsmans, Y
Van Hassel, M
Rahier, J
Reynaert, M
Geubel, A
Kestens, PJ
Otte, JB
Citation: J. Lerut et al., Adult liver transplantation: UCL experience, ACT GASTR B, 62(3), 1999, pp. 306-318
Authors:
Staerkel, P
Horsmans, Y
Citation: P. Staerkel et Y. Horsmans, Meloxicam-induced liver toxicity, ACT GASTR B, 62(2), 1999, pp. 255-256
Authors:
Leclercq, I
Horsmans, Y
De Bruyere, M
Geubel, AP
Citation: I. Leclercq et al., Influence of body mass index, sex and age on serum alanine aminotransferase (ALT) level in healthy blood donors, ACT GASTR B, 62(1), 1999, pp. 16-20
Authors:
Van Hoof, M
Joris, JP
Horsmans, Y
Geubel, A
Citation: M. Van Hoof et al., Acute renal failure requiring haemodialysis after high doses percutaneous acetic acid injection for hepatocellular carcinoma, ACT GASTR B, 62(1), 1999, pp. 49-51
Authors:
Leclercq, I
Horsmans, Y
Desager, JP
Citation: I. Leclercq et al., Estimation of chlorzoxazone hydroxylase activity in liver microsomes and of the plasma pharmacokinetics of chlorzoxazone by the same high-performanceliquid chromatographic method, J CHROMAT A, 828(1-2), 1998, pp. 291-296
Authors:
Verbeeck, RK
Horsmans, Y
Citation: Rk. Verbeeck et Y. Horsmans, Effect of hepatic insufficiency on pharmacokinetics and drug dosing, PHARM WORLD, 20(5), 1998, pp. 183-192
Authors:
Horsmans, Y
Citation: Y. Horsmans, Is antiviral treatment (IFN alpha and/or Ribavirin) justified in cirrhosisrelated to hepatitis C virus? Contra, ACT GASTR B, 61(4), 1998, pp. 434-436